VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy.
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy. Cancer. 2007 Jan 15; 109(2):248-55.
View in:
PubMed
subject areas
Adult
Aged
Anemia
Antineoplastic Agents, Phytogenic
Benzamides
Blast Crisis
Diarrhea
Dose-Response Relationship, Drug
Drug Administration Schedule
Fatigue
Female
Harringtonines
Humans
Imatinib Mesylate
Injections, Intravenous
Injections, Subcutaneous
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Nausea
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Treatment Failure
Treatment Outcome
authors with profiles
HAGOP M KANTARJIAN
ZEEV ESTROV
JORGE E CORTES
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO